BACKGROUND: Immune activation by immune checkpoint inhibitors (ICI) has shown promise in the treatment of diverse cancer types at the cost of different immune-related adverse events (irAEs)…
This session will delve into the intricate relationship between the gut microbiome and cancer, highlighting the role of specific microbial species in tumorigenesis and innovative diagnostic approaches…